Literature DB >> 7494027

Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing.

K Ouchi1, M Abe, M Karita, T Oguri, J Igari, T Nakazawa.   

Abstract

We analyzed strains of Burkholderia (formerly Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing methods. One hundred isolates of B. cepacia were obtained from patients at several wards in a single hospital from March 1983 to February 1984. These isolates were classified into 12 groups by a new biochemical typing scheme on the basis of the production of six enzymes and the production of hemolytic substance and yellow pigment. Among them, 33 strains collected from the 12 groups were further characterized by DNA fingerprinting by pulse-field gel electrophoresis, ribotyping, and plasmid profile analysis. Forty-seven strains of B. cepacia of independent origins and 25 isolates from the same hospital obtained 10 years later for a follow-up study were also subjected to analysis. Both DNA fingerprinting and ribotyping clearly discriminated the isolates from different hospitals. Of interest, although the biochemical typing and plasmid profiles of the isolates obtained during 1983 to 1984 in a single hospital were variable, genomic typing identified the majority of the isolates (32 of 33 [97%]) as derivatives of a single strain. Furthermore, a follow-up study suggested the persistence of such derivatives among the isolates after a decade. These results clearly indicated that the outbreak of B. cepacia infection in the hospital was nosocomial in origin. Thus, the usefulness of genomic typing for epidemiological studies of B. cepacia infection was further demonstrated. The biochemical typing revealed the marked variability of phenotypes of B. cepacia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494027      PMCID: PMC228411          DOI: 10.1128/jcm.33.9.2353-2357.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak.

Authors:  D J Anderson; J S Kuhns; M L Vasil; D N Gerding; E N Janoff
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  A broad-spectrum probe for molecular epidemiology of bacteria: ribosomal RNA.

Authors:  T L Stull; J J LiPuma; T D Edlind
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

3.  Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations.

Authors:  C S Rabkin; W R Jarvis; R L Anderson; J Govan; J Klinger; J LiPuma; W J Martone; H Monteil; C Richard; S Shigeta
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

4.  Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia.

Authors:  M L Vasil; D P Krieg; J S Kuhns; J W Ogle; V D Shortridge; R M Ostroff; A I Vasil
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

5.  Characterization of hemolysin in extracellular products of Pseudomonas cepacia.

Authors:  T Nakazawa; Y Yamada; M Ishibashi
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

6.  Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.

Authors:  O C Tablan; W J Martone; C F Doershuk; R C Stern; M J Thomassen; J D Klinger; J W White; L A Carson; W R Jarvis
Journal:  Chest       Date:  1987-04       Impact factor: 9.410

7.  Characterization of hemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia.

Authors:  M Abe; T Nakazawa
Journal:  Microbiol Immunol       Date:  1994       Impact factor: 1.955

8.  Subgrouping of Pseudomonas cepacia by cellular fatty acid composition.

Authors:  G M Mukwaya; D F Welch
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

9.  An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump.

Authors:  W A Rutala; D J Weber; C A Thomann; J F John; S M Saviteer; F A Sarubbi
Journal:  J Thorac Cardiovasc Surg       Date:  1988-07       Impact factor: 5.209

10.  Typing of Pseudomonas cepacia by bacteriocin susceptibility and production.

Authors:  J R Govan; G Harris
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

View more
  3 in total

1.  Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers.

Authors:  C Segonds; E Bingen; G Couetdic; S Mathy; N Brahimi; N Marty; P Plesiat; Y Michel-Briand; G Chabanon
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

2.  Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping.

Authors:  S Brisse; C M Verduin; D Milatovic; A Fluit; J Verhoef; S Laevens; P Vandamme; B Tümmler; H A Verbrugh; A van Belkum
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 3.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.